F. Hofmann (Germany): Molecular pharmacology of calcium channels.
A. Zanchetti (Italy): The view of a clinician on the bénéfice of calcium channel blockers in hypertension.
T. Godfraind (Belgium): CCBs control of gene reprogramming and gene upregulation in salt-dependent hypertension.
U. Ruegg (Switzerland): Pharmacology of cellular calcium regulation in neuromuscular diseases.
E. Ertel (Switzerland): Pharmacology of T-type calcium channels.